226 related articles for article (PubMed ID: 35603655)
1. [Research progress of targeting macrophage surface receptors in the treatment of inflammatory bowel disease].
Zhang L; Xu H; Wang T; Wang B; Zhang S; Zhang D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):460-465. PubMed ID: 35603655
[TBL] [Abstract][Full Text] [Related]
2. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics window into the diagnosis and treatment of inflammatory bowel disease in recent 5 years.
Wang J; Sun Q; Gao Y; Xiang H; Zhang C; Ding P; Wu T; Ji G
Int Immunopharmacol; 2022 Dec; 113(Pt B):109472. PubMed ID: 36435058
[TBL] [Abstract][Full Text] [Related]
4. [A practical guide to chronic inflammatory bowel disease].
Salvador Nunes L; Greuter T; Henchoz S; Schoepfer A
Rev Med Suisse; 2021 Sep; 17(748):1448-1452. PubMed ID: 34468095
[TBL] [Abstract][Full Text] [Related]
5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
6. Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease.
Dharmasiri S; Garrido-Martin EM; Harris RJ; Bateman AC; Collins JE; Cummings JRF; Sanchez-Elsner T
Inflamm Bowel Dis; 2021 Oct; 27(10):1641-1652. PubMed ID: 33570153
[TBL] [Abstract][Full Text] [Related]
7. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
[TBL] [Abstract][Full Text] [Related]
8. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.
Forabosco P; Collins A; Latiano A; Annese V; Clementi M; Andriulli A; Fortina P; Devoto M; Morton NE
Eur J Hum Genet; 2000 Nov; 8(11):846-52. PubMed ID: 11093274
[TBL] [Abstract][Full Text] [Related]
9. Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
Zhang C; Liu X
Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102214. PubMed ID: 37748580
[TBL] [Abstract][Full Text] [Related]
10. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-modifying enzymes as regulators of colitis.
Ruan J; Schlüter D; Naumann M; Waisman A; Wang X
Trends Mol Med; 2022 Apr; 28(4):304-318. PubMed ID: 35177326
[TBL] [Abstract][Full Text] [Related]
12. Recent understanding of IBD pathogenesis: implications for future therapies.
Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
[TBL] [Abstract][Full Text] [Related]
13. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
14. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
Jakubczyk D; Leszczyńska K; Górska S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in the Treatment of Inflammatory Bowel Disease.
Guandalini S; Sansotta N
Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
[TBL] [Abstract][Full Text] [Related]
16. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
[TBL] [Abstract][Full Text] [Related]
17. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease: one or two diseases?
Sachar DB; Walfish A
Curr Gastroenterol Rep; 2013 Jan; 15(1):298. PubMed ID: 23250698
[TBL] [Abstract][Full Text] [Related]
19. Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity.
Zhong G; He C; Wang S; Lin C; Li M
Front Immunol; 2023; 14():1241262. PubMed ID: 37720208
[TBL] [Abstract][Full Text] [Related]
20. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
